GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $523,000 | +56.1% | 2,411 | -16.9% | 0.00% | – |
| Q4 2020 | $335,000 | +18.8% | 2,900 | 0.0% | 0.00% | – |
| Q3 2020 | $282,000 | -23.4% | 2,900 | -3.3% | 0.00% | – |
| Q2 2020 | $368,000 | +39.9% | 3,000 | 0.0% | 0.00% | – |
| Q1 2020 | $263,000 | -16.2% | 3,000 | 0.0% | 0.00% | – |
| Q4 2019 | $314,000 | -9.0% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $345,000 | -12.9% | 3,000 | +30.4% | 0.00% | – |
| Q2 2019 | $396,000 | +2.1% | 2,300 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $388,000 | +73.2% | 2,300 | 0.0% | 0.00% | – |
| Q4 2018 | $224,000 | -13.5% | 2,300 | +53.3% | 0.00% | – |
| Q3 2018 | $259,000 | +23.9% | 1,500 | 0.0% | 0.00% | – |
| Q2 2018 | $209,000 | +43.2% | 1,500 | +15.4% | 0.00% | – |
| Q1 2018 | $146,000 | +121.2% | 1,300 | +160.0% | 0.00% | – |
| Q4 2017 | $66,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |